MFG
BIIB icon

Merit Financial Group’s Biogen BIIB Stock Holding History

Merit Financial Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.75M Buy
12,725
+1,295
+11% +$248K 0.02% 614
2026
Q1 		$2.1M Buy
11,430
+913
+9% +$168K 0.02% 663
2025
Q4 		$1.85M Buy
10,517
+2,150
+26% +$351K 0.01% 677
2025
Q3 		$1.17M Buy
8,367
+1,376
+20% +$186K 0.01% 783
2025
Q2 		$878K Sell
6,991
-2,006
-22% -$250K 0.01% 856
2025
Q1 		$1.23M Buy
8,997
+6,066
+207% +$867K 0.02% 581
2024
Q4 		$448K Buy
+2,931
New +$494K 0.01% 765

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Merit Financial Group's BIIB Position: Q2 2026 in Review

Merit Financial Group increased its Biogen (BIIB) stake by 11% in Q2 2026, buying an estimated $248K and bringing the position to 12,725 shares worth $2.75M. The position accounts for 0.02% of the portfolio, ranked #614.

Merit Financial Group first reported a position in BIIB in Q4 2024 and has held it in 7 quarters since. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Merit Financial Group held 12,725 shares of Biogen worth $2.75M as of Q2 2026.
  • Merit Financial Group bought 1,295 Biogen shares in Q2 2026, an estimated $248K.
  • Biogen made up 0.02% of Merit Financial Group's portfolio in Q2 2026, its #614 holding.
  • Merit Financial Group first reported a position in Biogen in Q4 2024 and has held it in 7 quarters since.
  • 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.